Patents by Inventor Mark W. Tibbitt

Mark W. Tibbitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11517538
    Abstract: Network materials which exhibit both shear thinning and self-healing properties are disclosed. The networks contain particles and gel-forming compounds. The networks are useful for a variety of biomedical uses, including drug delivery.
    Type: Grant
    Filed: June 8, 2021
    Date of Patent: December 6, 2022
    Assignee: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
    Inventors: Eric A. Appel, Mark W. Tibbitt, Robert S. Langer
  • Publication number: 20220142919
    Abstract: The present invention provides dynamically covalent polymeric hydrogel systems for encapsulating and stabilizing bioactive therapeutic agents (e.g., proteins, cells, viruses, and vaccines) from environmental stressors, obviating standard refrigeration requirements, and decreasing transportation and storage costs of temperature-sensitive biomolecules. Described herein are dynamic polymeric hydrogel compositions comprising a therapeutic agent and a combination of phenylboronic acid- and 1,2-diol-modified multi-arm polyethylene glycol (PEG) polymer backbones. Methods of encapsulating and stabilizing bioactive therapeutic agents within the dynamic polymeric hydrogel compositions are also provided. Also described are methods for releasing stabilized therapeutic agents from hydrogel encapsulation.
    Type: Application
    Filed: March 5, 2020
    Publication date: May 12, 2022
    Applicant: Nanoly Bioscience, Inc.
    Inventors: Bruno Marco-Dufort, Mark W. Tibbitt, Balaji V. Sridhar, John R. Janczy, David Busha, Margaret Best
  • Patent number: 11262361
    Abstract: Disclosed herein are photodegradable hydrogels and associated kits for selectively capturing and releasing cells. The hydrogels result from cross linking in the presence of a photoinitiator (1) a macromer having a polymeric backbone structure, a photo labile moiety, and a first linking moiety, and (2) a cell-binding moiety having a second linking moiety. These two components are cross-linked by a polymerization reaction of the linking moieties to form a photodegradable hydrogel incorporating the cell-binding moiety within the hydrogel. Also disclosed are methods of making the hydrogels, and methods of using the hydrogels for selectively capturing and releasing cells and for detecting cells in a fluid. Such methods can be used to detect the presence and quantity of certain rare cell types in a biological fluid.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: March 1, 2022
    Assignee: The General Hospital Corporation
    Inventors: Mark W. Tibbitt, Kristi S. Anseth, April M. Kloxin, Mehmet Toner, John Oakey, Ajay Shah
  • Publication number: 20210369633
    Abstract: Network materials which exhibit both shear thinning and self-healing properties are disclosed. The networks contain particles and gel-forming compounds. The networks are useful for a variety of biomedical uses, including drug delivery.
    Type: Application
    Filed: June 8, 2021
    Publication date: December 2, 2021
    Inventors: Eric A. Appel, Mark W. Tibbitt, Robert S. Langer
  • Patent number: 11045429
    Abstract: Network materials which exhibit both shear thinning and self-healing properties are disclosed. The networks contain particles and gel-forming compounds. The networks are useful for a variety of biomedical uses, including drug delivery.
    Type: Grant
    Filed: January 23, 2017
    Date of Patent: June 29, 2021
    Assignee: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
    Inventors: Eric A. Appel, Mark W. Tibbitt, Robert S. Langer
  • Publication number: 20190091346
    Abstract: A photodegradable polymeric system is presented that can be employed to entrap and stabilize bioactive therapeutics such as proteins and vaccines from environmental stressors. This system would obviate the need for refrigeration and would decrease transportation and storage costs of temperature-sensitive therapeutics. By using a photosensitive release system, users can administer temperature-sensitive compounds at their discretion. This photodegradable system will also permit the potential to stabilize temperature-sensitive therapeutics in a liquid suspension, eliminating the need for reconstitution.
    Type: Application
    Filed: November 29, 2018
    Publication date: March 28, 2019
    Applicant: Nanoly Bioscience, Inc.
    Inventors: Balaji V. Sridhar, Mark W. Tibbitt, Oyvind Hatlevik, Jacob W. Heaps, John Janczy
  • Publication number: 20170319506
    Abstract: Network materials which exhibit both shear thinning and self-healing properties are disclosed. The networks contain particles and gel-forming compounds. The networks are useful for a variety of biomedical uses, including drug delivery.
    Type: Application
    Filed: January 23, 2017
    Publication date: November 9, 2017
    Inventors: Eric A. Appel, Mark W. Tibbitt, Robert S. Langer
  • Publication number: 20160153999
    Abstract: Disclosed herein are photodegradable hydrogels and associated kits for selectively capturing and releasing cells. The hydrogels result from cross linking in the presence of a photoinitiator (1) a macromer having a polymeric backbone structure, a photo labile moiety, and a first linking moiety, and (2) a cell-binding moiety having a second linking moiety. These two components are cross-linked by a polymerization reaction of the linking moieties to form a photodegradable hydrogel incorporating the cell-binding moiety within the hydrogel. Also disclosed are methods of making the hydrogels, and methods of using the hydrogels for selectively capturing and releasing cells and for detecting cells in a fluid. Such methods can be used to detect the presence and quantity of certain rare cell types in a biological fluid.
    Type: Application
    Filed: July 18, 2014
    Publication date: June 2, 2016
    Inventors: Mark W. Tibbitt, Kristi S. Anseth, April M. Kloxin, Mehmet Toner, John Oakey, Ajay Shah
  • Patent number: 9180196
    Abstract: Here, we present a photodegradable microparticle system that can be employed to entrap and deliver bioactive proteins to cells during culture. By using a photosensitive delivery system, experimenters can achieve a wide variety of spatiotemporally regulated release profiles with a single microparticle formulation, thereby enabling one to probe many questions as to how protein presentation can be manipulated to regulate cell function. Photodegradable microparticles were synthesized via inverse suspension polymerization with a mean diameter of 22 ?m, and degradation was demonstrated upon exposure to several irradiation conditions. The protein-loaded depots were incorporated into cell cultures and release of bioactive protein was quantified during the photodegradation process. This phototriggered release allowed for the delivery of TGF-?1 to stimulate PE25 cells and for the delivery of fluorescently labeled Annexin V to assay apoptotic 3T3 fibroblasts during culture.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: November 10, 2015
    Assignee: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Kristi S. Anseth, Andrea M. Kasko, Mark W. Tibbitt, April M. Kloxin, Balaji Sridhar
  • Publication number: 20140031285
    Abstract: Here, we present a photodegradable microparticle system that can be employed to entrap and deliver bioactive proteins to cells during culture. By using a photosensitive delivery system, experimenters can achieve a wide variety of spatiotemporally regulated release profiles with a single microparticle formulation, thereby enabling one to probe many questions as to how protein presentation can be manipulated to regulate cell function. Photodegradable microparticles were synthesized via inverse suspension polymerization with a mean diameter of 22 ?m, and degradation was demonstrated upon exposure to several irradiation conditions. The protein-loaded depots were incorporated into cell cultures and release of bioactive protein was quantified during the photodegradation process. This phototriggered release allowed for the delivery of TGF-?1 to stimulate PE25 cells and for the delivery of fluorescently labeled Annexin V to assay apoptotic 3T3 fibroblasts during culture.
    Type: Application
    Filed: December 21, 2012
    Publication date: January 30, 2014
    Inventors: Kristi S. Anseth, Andrea M. Kasko, Mark W. Tibbitt, April M. Kloxin, Balaji Sridhar